The heterostructure of ZnO and MOF-46(Zn) was synthesized to improve the photocatalytic performance of ZnO and prove the synergistic theory that presented the coexistence of ZnO and MOF-46(Zn), providing better efficiency than pure ZnO. The heterostructure material was synthesized by using prepared ZnO as a Zn²⁺ source, which was reacted with 2-aminoterephthalic acid (2-ATP) as a ligand to cover the surface of ZnO with MOF-46(Zn). The ZnO reactant materials were modified by pyrolysis of various morphologies of IRMOF-3 (Zn-MOF) prepared by using CTAB as a morphology controller. The octahedral ZnO obtained at 150 mg of CTAB shows better efficiency for photodegradation, with 85.79% within 3 h and a band gap energy of 3.11 eV. It acts as a starting material for synthesis of ZnO@MOF-46(Zn). The ZnO/MOF-46(Zn) composite was further used as a photocatalyst material in the dye (methylene blue: MB) degradation process, and the performance was compared with that of pure prepared ZnO. The results show that the photocatalytic efficiency with 61.20% in the MB degradation of the heterostructure is higher than that of pure ZnO within 60 min (90.09% within 180 min). The reason for this result may be that the coexistence of ZnO and MOF-46(Zn) can absorb a larger range of energy and reduce the possibility of the electron–hole recombination process.

The Zn(8-hydroxyquinoline)₂(H₂O)₂, ZnQ₂·2H₂O, encapsulated in the porous BioMOF1 (ZnQ₂@BioMOF1) host was synthesized by solid-solid and solid-solution reaction between Zn²⁺@BioMOF1 and 8-hydroxyquinoline. To prepare Zn²⁺@BioMOF1, dimethylammonium (DMA⁺), guests in the pores of BioMOF1 were replaced by Zn²⁺ ions via ion exchange process. The synthesized compound was characterized by XRD and TGA to confirm stability of BioMOF1 host. The ZnQ₂·2H₂O forming by metal-cation-directed de novo coassembly approach was confirmed by UV, IR, Fluorescence, BET, and confocal microscopy. Scanning electron microscopy images show slight change in morphology of BioMOF1 after introducing ZnQ₂·2H₂O by solid-solution reaction into its pores. Thin films of the produced materials were used to sense dissolved oxygen in water by using fluorescence technique.

In the title compound, C₉H₁₀ClNOS, the amide functional group –C(=O)NH– adopts a trans conformation with the four atoms nearly coplanar. This conformation promotes the formation of a C(4) hydrogen-bonded chain propagating along the [010] direction. The central part of the molecule, including the six-membered ring, the S and N atoms, is fairly planar (r.m.s. deviation of 0.014). The terminal methyl group and the C(=O)CH₂ group are slightly deviating out-of-plane while the terminal Cl atom is almost in-plane. Hirshfeld surface analysis of the title compound suggests that the most significant contacts in the crystal are H...H, H...Cl/Cl...H, H...C/C...H, H...O/O...H and H...S/S...H. π–π interactions between inversion-related molecules also contribute to the crystal packing. DFT calculations have been performed to optimize the structure of the title compound using the CAM-B3LYP functional and the 6–311 G(d,p) basis set. The theoretical absorption spectrum of the title compound was calculated using the TD–DFT method. The analysis of frontier orbitals revealed that the π–π* electronic transition was the major contributor to the absorption peak in the electronic spectrum.

The title compound, C(17)H(21)NO(4), shows an intra-molecular hydrogen bond between a phenol OH group and the N atom. In the crystal, mol-ecules are connected by pairs of O-H⋯O hydrogen bonds into inversion dimers.

Melotenine A, isolated from Melodinus tenuicaudatus, possesses significant anticancer activity against several human cancer cell lines. The synthesis of (±)-melotenine A was achieved without the use of any protecting groups in 11 steps with an overall yield of 6.7%. The key steps of our strategy were a Diels–Alder reaction to construct the tetracyclic framework and ring-closing metathesis to form the seven-membered ring of (±)-melotenine A.